AFP and neoplasm: We found that serum miR-150 levels were significantly associated with TNM and BCLC stages (P < 0.0001) (Fig. 3), while there was no significant association of miR-150 with clinical features such as gender, age, AFP levels, tumor diameter and differentiation (P > 0.05).